5-amino-1mq and cd38 inhibitor synergy nad+ Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator Emerging Therapeutic Target Dysregulation of Niacin-Derived NAD+ Salvage
Dysregulation of Niacin Derived NAD+ Salvage Pathway Markers (CD38, NAMPT, SIRT1) Across Albuminuria Stages in Type 2 Diabetes A Potent and Specific CD38 Inhibitor Ameliorates Age Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline ScienceDirect The Pharmacology of CD38 NADase: An emerging target for cancer and aging diseases PMC Selective and membrane permeable small molecule inhibitors of nicotinamide N methyltransferase reverse high fat diet induced obesity in mice PMC NAD+ metabolism and its roles in cellular processes during ageing PMC
Pay in 4 interest-free payments of $6.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19




